New York Stock Exchange listed
Johnson & Johnson (JNJ) reported
last week Q4 2013 sales of $18.4b,
an increase of 4.5% vs Q4 for the
previous year.
Full year sales for 2013 were
$71.3b, up 6.1% from 2012
reported The Wall Street Journal.
The pharmaceutical business
was the key driver with strong
performance also by key OTC and
other consumer brands especially
Tylenol, Motrin, Neutrogena,
Aveeno and Listerine.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jan 14
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.